Skip to main content
. 2020 Nov 1;17(21):8056. doi: 10.3390/ijerph17218056

Figure 2.

Figure 2

Flowchart of enrollment, clinical examinations, and derivation of the GWAS analytical samples in the ZOE 2.0 study, North Carolina, United States (the 19 participants that are identified with protocol deviations that were withdrawn, or discontinued were initially considered as part of enrollment, but were removed from the study enrollment and do not count towards the reported enrollment figure of 8059).